Trade KAPA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Kairos Pharma, Ltd. (KAPA) is trading at US$0.24, down 0.41% today as of Aug 28, 12:36 EDT. The company has a market capitalisation of US$6.87M. Over the past 52 weeks, KAPA has traded between US$0.22 and US$2.11. On Syfe you can trade KAPA with $0 commission and add it to your watchlist.
| Previous close | US$0.24 |
|---|---|
| Market cap | US$6.87M |
| 52-week range | US$0.22 – US$2.11 |
| Volume | 438.8K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kairos Pharma, Ltd.
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Year: 2024
Kairos Pharma Collaborates With Bayer to Assess Prostate Cancer Treatment Combination
Jul 22, 1:08 PM · MT Newswires
Kairos Pharma, Ltd. (KAPA) stock is trading at US$0.24, -0.41% from the previous close of US$0.24.
The market cap for Kairos Pharma, Ltd. (KAPA) stock is approximately US$6.87M.
The 52-week high for Kairos Pharma, Ltd. (KAPA) stock is US$2.11.
The 52-week low for Kairos Pharma, Ltd. (KAPA) stock is US$0.22.
Kairos Pharma, Ltd. (KAPA) does not currently pay a dividend.
Stay on top of KAPA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
